← Open Payments lookup

MARK STRICKLAND: Open Payments

NPI 1538110325 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,979 in 97 payments from 16 companies in 2025. Trend: 2023 $1,451 · 2024 $1,825 · 2025 $1,979

Food & beverage: $1,979
CompanyPaymentsAmount
ABBVIE INC.16$278
Vanda Pharmaceuticals Inc.12$267
Takeda Pharmaceuticals U.S.A., Inc.11$235
Otsuka America Pharmaceutical, Inc.12$172
Teva Pharmaceuticals USA, Inc.7$167
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$123
Axsome Therapeutics, Inc.6$123
Almatica Pharma LLC6$115
E.R. Squibb & Sons, L.L.C.5$114
Alkermes, Inc.6$103

Products named: VRAYLAR, FANAPT, TRINTELLIX, REXULTI, AUSTEDO XR, CAPLYTA, LOREEV XR, COBENFY.

Industry payments across FL — which companies pay providers there.